WithMe Health, Inc., a San Mateo, CA-based medication guidance company, closed a $20m Series B financing round.
The round was led by Omers Ventures with participation from existing investor Oak HC/FT, along with new investors Section 32, Shulman Ventures and MTS Ventures. In conjunction with the funding, Michael Yang, Managing Partner of OMERS Ventures, will join WithMe Health’s Board of Directors and Brian Marcotte, past CEO and President of the Business Group on Health, will join the Advisory Board.
The company intends to use the funds for further growth of the client base as well as an extension of the core offering.
Led by Joe Murad, Chief Executive Officer, WithMe Health provides a full-service replacement for traditional PBMs and is launching a medication guidance service that complements plan sponsors’ existing PBM infrastructure by personalizing medication selection and member guidance. The service helps employers and health plans curb their costs while optimizing member experience and outcomes.
WithMe Health tailors medication recommendations and member support to an individual’s needs and context by assimilating multiple data sources (pharmacy, medical and lab) to develop an integrated clinical point-of-view. A team of clinical pharmacists, called Medication Guides, then engages with members to guide them to the best possible outcome. These interactions are supported by a proprietary underlying engagement model based in behavioral and economic psychology called MEDS (Meet, Evaluate, Decide, Support).